newsfilter
← Latest News
GlobeNewswire·

Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026

FOSTER CITY, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a hematology-focused commercial stage biopharmaceutical company pursuing more meaningful moments for people living with blood